A

Axsome Therapeutics

Biopharmaceutical company developing CNS disorder therapies

Associate Director - HEOR Analytics

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-timeNew York, NY, USA

About the Job

Requirements

  • A PhD or Master's degree in Biostatistics, Epidemiology, Health Economics, Data Science, or a related quantitative field is required.
  • At least 5 years of experience conducting analyses using real-world healthcare data, including claims, electronic health records, or registries.
  • Ability to work on site Monday, Tuesday, and Thursday; fully remote candidates are not considered.
  • Experience designing and executing observational and retrospective studies.
  • Track record of generating real-world evidence to support publications or market access.
  • Strong programming skills in SAS, R, Python, and/or SQL.
  • Expertise in statistical methods such as regression, survival analysis, and causal inference.
  • Hands-on experience with large healthcare databases and data structures.
  • Experience with cohort construction and data transformation.

Responsibilities

  • Lead development of analytical strategies supporting HEOR, Medical Affairs, and market access evidence generation.
  • Design appropriate methodologies, including traditional statistical approaches and advanced analytics such as survival analysis, comparative effectiveness, treatment patterns, healthcare resource utilization, and machine learning where appropriate.
  • Apply epidemiologic and statistical methodologies to address bias, confounding, and missing data in real-world datasets.
  • Contribute to protocol development, database specifications, and statistical analysis plans.
  • Ensure methodological rigor, reproducibility, and compliance with regulatory and industry standards.
  • Perform and oversee statistical programming and analysis using SAS, R, Python, and SQL.
  • Develop and validate analysis-ready datasets and analytic workflows from raw healthcare data sources.
  • Lead cohort identification using clinical coding systems such as ICD, CPT, and NDC.
  • Support data acquisition strategy by identifying appropriate claims, EHR, and other real-world data sources.
  • Partner with IT and Commercial Operations on real-world database ingestion into the company's data ecosystem.
  • Translate analytical results into actionable insights for non-technical stakeholders using graphics, slides, and dashboards as appropriate.
  • Contribute to the development of abstracts, presentations, and manuscripts.
  • Support development of payer evidence and value dossiers.
  • Present findings to internal and external stakeholders, including at scientific meetings.
  • Partner with HEOR strategy leads and Medical Affairs teams, as well as Commercial and Market Access analytics as appropriate.
  • Translate business needs into analytical solutions.
  • Manage and oversee external vendors and CROs conducting HEOR/RWE analyses.
  • Serve as a technical leader in HEOR analytics and promote best practices.
  • Stay current with evolving RWE methodologies and analytics tools.
  • Contribute to continuous improvement of HEOR analytics processes and standards.

About the Company

Axsome Therapeutics

Biopharmaceutical company developing CNS disorder therapies

Axsome Therapeutics develops therapies for central nervous system disorders. Its focus is on research, development, and commercialization of treatments for conditions such as major depressive disorder, treatment-resistant depression, Alzheimer's agitation, migraine, narcolepsy, fibromyalgia, and smoking cessation. The flagship product candidate, AXS-05, is an oral NMDA receptor antagonist intended to treat MDD and TRD; it works by blocking NMDA receptors to influence brain signaling involved in mood and depression, and has received FDA Breakthrough Therapy Designation. The company earns revenue from the commercialization of its drugs, partnerships, and potential licensing deals as its pipeline progresses through clinical trials and regulatory approvals. Axsome aims to provide effective CNS therapies, advance its drug pipeline, and improve patient outcomes and quality of life.

Company size
501-1,000
Company stage
IPO
Headquarters
New York City, New York
Founded
2012

Recently Posted Jobs

Explore more opportunities at Axsome Therapeutics

See more jobs